Immunogen (IMGN) Tops Q3 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Financial Fact:
Research and development support: 1.35M
Today's EPS Names:
KELYA, ROX, KEEL, More
Financial Fact:
Research and development support: 1.35M
Today's EPS Names:
KELYA, ROX, KEEL, More
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) reported Q3 EPS of $0.10, $0.06 better than the analyst estimate of $0.04. Revenue for the quarter came in at $113.4 million versus the consensus estimate of $103.68 million.
For earnings history and earnings-related data on Immunogen (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Loar Holdings Inc. (LOAR) Reports Q3 EPS of $0.39 ; Offers Guidance
- Vericel (VCEL) Tops Q3 EPS by 21c; Offers Guidance
- Privia Health Group, Inc. (PRVA) Tops Q3 EPS by 12c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
